[1] |
VILLANUEVA A. Hepatocellular carcinoma[J]. N Engl J Med, 2019, 380(15): 1450-1462. DOI: 10.1056/NEJMra1713263.
|
[2] |
LLOVET JM, KELLEY RK, VILLANUEVA A, et al. Hepatocellular carcinoma[J]. Nat Rev Dis Primers, 2021, 7(1): 6. DOI: 10.1038/s41572-020-00240-3.
|
[3] |
European Association for the Study of the Liver. EASL clinical practice guidelines: Management of hepatocellular carcinoma[J]. J Hepatol, 2018, 69(1): 182-236. DOI: 10.1016/j.jhep.2018.03.019.
|
[4] |
MARRERO JA, KULIK LM, SIRLIN CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases[J]. Hepatology, 2018, 68(2): 723-750. DOI: 10.1002/hep.29913.
|
[5] |
RODRIGUEZ H, ZENKLUSEN JC, STAUDT LM, et al. The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment[J]. Cell, 2021, 184(7): 1661-1670. DOI: 10.1016/j.cell.2021.02.055.
|
[6] |
FONTHAM E, WOLF A, CHURCH TR, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society[J]. CA Cancer J Clin, 2020, 70(5): 321-346. DOI: 10.3322/caac.21628.
|
[7] |
MCCLUNG NM, LEWIS RM, GARGANO JW, et al. Declines in vaccine-type human papillomavirus prevalence in Females Across Racial/Ethnic Groups: Data from a national survey[J]. J Adolesc Health, 2019, 65(6): 715-722. DOI: 10.1016/j.jadohealth.2019.07.003.
|